Neoadjuvant therapy for pancreatic cancer
Author:
Affiliation:
1. Department of General Surgery, University of Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany
Abstract
Publisher
Oxford University Press (OUP)
Subject
Surgery
Link
http://academic.oup.com/bjs/article-pdf/94/3/261/36687075/bjs5737.pdf
Reference10 articles.
1. Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer: phase I trial results;Czito;J Clin Oncol,2006
2. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: the French SFRO-FFCD 97-04 Phase II trial;Mornex;Int J Radiat Oncol Biol Phys,2006
3. Docetaxel/ Gemcitabine followed by gemcitabine and external beam radiotherapy in patients with pancreatic adenocarcinoma;Pipas;Ann Surg Oncol,2005
4. Systematic review and meta-analysis of standard and extended lymphadenectomy in pancreaticoduodenectomy for pancreatic cancer;Michalski;Br J Surg,2007
5. Randomized phase II—study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer—PARC: study protocol [ISRCTN56652283];Krempien;BMC Cancer,2005
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Májáttétes pancreasrák: meghosszabbítható-e a túlélés az oligoperzisztens primer daganat neoadjuváns kemoterápiát követő reszekciójával?;Orvosi Hetilap;2023-10-29
2. Neoadjuvant therapy could improve survival outcomes of locally advanced biliary tract cancer by increasing opportunities for curative resection: a systematic review and meta-analysis;2023-09-12
3. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients;PLOS ONE;2022-03-11
4. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid;Human Cell;2022-02-12
5. A look at the progress of treating pancreatic cancer over the past 20 years;Expert Review of Anticancer Therapy;2018-01-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3